Aurobindo Pharma gets DCGI nod for Molnupiravir generic version
Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More
Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention
Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine
Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 ... Read More
Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V
Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India ... Read More
India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines
The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech's Covaxin vaccines for the prevention ... Read More
India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines
The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin vaccines for the prevention ... Read More
Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company ... Read More
Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico
Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with ... Read More
Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine
BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their ... Read More
Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt
Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More